CORE--TRANSGENIC MOUSE

$0P01FY2000DKNIH

Harvard University (Medical School), Boston MA

Investigators

Linked publications & trials

Paper 36070691 Paper 30843886 Paper 28627474 Paper 28129848 Paper 27814929 Paper 27471255 Paper 27357142 Paper 27134141 Paper 26526380 Paper 26455300 Paper 26146088 Paper 26052897 Paper 25603997 Paper 25419849 Paper 25240456 Paper 24982242 Paper 24916175 Paper 24823377 Paper 24823376 Paper 24803652 Paper 24781502 Paper 24218567 Paper 24151335 Paper 23505158 Paper 23485973 Paper 23475960 Paper 23356643 Paper 21173257 Paper 20708594 Paper 20059955 Paper 19874086 Paper 19815519 Paper 19607824 Paper 18957542 Paper 18927151 Paper 18684091 Paper 18602913 Paper 18434416 Paper 18395198 Paper 18238902 Paper 18083926 Paper 18028899 Paper 17988255 Paper 17967876 Paper 17670790 Paper 17567668 Paper 17497702 Paper 17199045 Paper 17194222 Paper 16905129 Paper 16854976 Paper 16476422 Paper 16421188 Paper 16322106 Paper 16122729 Paper 15965468 Paper 15951842 Paper 15880431 Paper 15771625 Paper 15634692 Paper 15465485 Paper 15459318 Paper 15353802 Paper 15302603 Paper 15253939 Paper 15124025 Paper 15107405 Paper 14973297 Paper 14701876 Paper 14512017 Paper 12705871 Paper 12586782 Paper 12569130 Paper 12569124 Paper 12208857 Paper 12200160 Paper 11748145 Paper 11714677 Paper 11585810 Paper 11160153 Paper 10631175

Abstract

Description: (Taken directly from the application) The aim of this Core is to develop transgenic mouse strains either by pronuclear injection of DNA or by blastocyst injection of genetically modified embryonic stem (ES) cells. These procedures not only require considerable skill they require dedicated equipment and facilities. The Core will facilitate genetic approaches which underpin each of the projects in this program. It will facilitate in training individuals from member laboratories who are unfamiliar with these procedures.

View original record on NIH RePORTER →